{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:47:17Z","timestamp":1780472837329,"version":"3.54.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Streptococcal toxic shock syndrome is a severe complication of group A streptococci. The production of antiphospholipid antibodies has been associated with streptococcal infections and with autoimmune diseases. Furthermore, streptococcal infections could be a trigger of Behcet's disease. We report a case of a boy who presented antiphospholipid syndrome after streptococcal toxic shock syndrome later he was diagnosed with Behcet's disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mbc.0000000000001189","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T20:56:42Z","timestamp":1675371402000},"page":"221-223","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Antiphospholipid syndrome after streptococcal toxic shock syndrome later diagnosed as Behcet's disease"],"prefix":"10.1097","volume":"34","author":[{"given":"Afroditi","family":"Kourti","sequence":"first","affiliation":[{"name":"3rd Department of Pediatrics of University of Athens, \u201cAttikon\u201d University General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lida","family":"Mentesidou","sequence":"additional","affiliation":[{"name":"1st Department of Pediatrics, \u2018Panagiotis and Aglaia Kyriakou\u2019 Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Michalopoulou","sequence":"additional","affiliation":[{"name":"Haemophilia Centre\/Haemostasis and Thrombosis Unit, \u201cAghia Sophia\u201d Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despoina","family":"Maritsi","sequence":"additional","affiliation":[{"name":"2nd Department of Pediatrics of University of Athens, Panagiotis and Aglaia Kyriakou Children's Hospital, Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Bachou","sequence":"additional","affiliation":[{"name":"1st Department of Pediatrics, \u2018Panagiotis and Aglaia Kyriakou\u2019 Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,12,26]]},"reference":[{"key":"R1-20250617","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198907063210101","article-title":"Reappearance of scarlet fever toxin A among streptococci in the Rocky Mountain West: severe group A streptococcal infections associated with toxic shock-like syndrome","volume":"321","author":"Stevens","year":"1989","journal-title":"N Engl J Med"},{"key":"R3-20250617","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1067\/mai.2001.117820","article-title":"Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related issues","volume":"108","author":"Schlievert","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"R4-20250617","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.1993.03500030088038","article-title":"Defining the group A streptococcal toxic shock syndrome","volume":"269","author":"Breiman","year":"1993","journal-title":"JAMA"},{"key":"R6-20250617","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1086\/515012","article-title":"Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome","volume":"27","author":"Eriksson","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R7-20250617","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1542\/peds.105.5.e60","article-title":"Invasive group A streptococcal disease in children and association with varicella-zoster virus infection","volume":"105","author":"Laupland","year":"2000","journal-title":"Pediatrics"},{"key":"R8-20250617","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2003.014175","article-title":"Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients","volume":"63","author":"Cervera","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"R9-20250617","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bcmd.2017.02.009","article-title":"Diagnosis and treatment of antiphospholipid syndrome in childhood: a review","volume":"67","author":"Rumsey","year":"2017","journal-title":"Blood Cells Mol Dis"},{"key":"R10-20250617","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.autrev.2017.12.006","article-title":"Beh\u00e7et's disease: new insights into pathophysiology, clinical features and treatment options","volume":"17","author":"Greco","year":"2017","journal-title":"Autoimmun Rev"},{"key":"R11-20250617","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3109\/s10165-012-0736-4","article-title":"A case of Beh\u00e7et's disease developing after poststreptococcal acute glomerulonephritis","volume":"23","author":"Kitai","year":"2013","journal-title":"Mod Rheumatol"},{"key":"R12-20250617","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1086\/519936","article-title":"Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden","volume":"45","author":"Darenberg","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R13-20250617","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/00006454-199110000-00017","article-title":"Toxic shock-like syndrome, a complication of strep throat","volume":"10","author":"Bradley","year":"1991","journal-title":"Pediatr Infect Dis J"},{"key":"R14-20250617","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/cid\/ciu304","article-title":"Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contracts, in invasive group A streptococcal infections","volume":"59","author":"Carapetis","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R15-20250617","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13613-018-0438-y","article-title":"Streptococcal toxic shock syndrome in the intensive care unit","volume":"8","author":"Schmitz","year":"2018","journal-title":"Ann Intensive Care"},{"key":"R16-20250617","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00277-005-1043-3","article-title":"Diffuse venous thromboemboli associated with IVIG therapy in the treatment of streptococcal toxic shock syndrome: case report and review","volume":"84","author":"Geller","year":"2005","journal-title":"Ann Hematol"},{"key":"R17-20250617","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000045472","article-title":"Anticardiolipin antibodies in acute poststreptococcal glomerulonephritis and streptococcal impetigo","volume":"83","author":"Ardiles","year":"1999","journal-title":"Nephron"},{"key":"R18-20250617","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1191\/096120301701548526","article-title":"Anticardiolipin antibodies are not associated with rheumatic heart disease","volume":"10","author":"Ilarraza","year":"2001","journal-title":"Lupus"},{"key":"R19-20250617","first-page":"1175","article-title":"Anticardiolipin antibodies in acute rheumatic fever","volume":"19","author":"Figueroa","year":"1992","journal-title":"J Rheumatol"},{"key":"R20-20250617","first-page":"338","article-title":"The International Criteria for Behcet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria","volume":"28","author":"Davatchi","year":"2014","journal-title":"JEADV"},{"key":"R21-20250617","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/1346-8138.13381","article-title":"Behcet's disease: a comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions","volume":"43","author":"Alpsoy","year":"2016","journal-title":"J Dermatol"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MBC.0000000000001189","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T23:08:37Z","timestamp":1750201717000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MBC.0000000000001189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,26]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0000000000001189","relation":{},"ISSN":["0957-5235","1473-5733"],"issn-type":[{"value":"0957-5235","type":"print"},{"value":"1473-5733","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,26]]}}}